The National Heart, Lung, and Blood Institute has awarded a five-year, $18 million grant to the Washington University School of Medicine in St. Louis for research on nanotechnology-based treatments and diagnostic agents for heart and lung diseases. The university will be collaborating with four other institutions -- two in Texas and two in California -- for this initiative.

Full Story:

Related Summaries